PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, 1180 Vienna, Austria.\', \'Center for Virology, Medical University of Vienna, 1090 Vienna, Austria.\', \'Department of Biotechnology, University of Natural Resources and Life Sciences, 1180 Vienna, Austria.\', \'Core Facility Mass Spectrometry, University of Natural Resources and Life Sciences, 1180 Vienna, Austria.\', \'The Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, AZ 85281.\', \'Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, 1180 Vienna, Austria; herta.steinkellner@boku.ac.at.\']
?:citedBy
  • -1
?:creator
?:doi
  • e210724911810.1073/pnas.2107249118
?:doi
?:hasPublicationType
?:journal
  • Proceedings of the National Academy of Sciences of the United States of America
is ?:pmid of
?:pmid
?:pmid
  • 34599091
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.092
?:rankingScore_hIndex
  • 675
?:title
  • Highly active engineered IgG3 antibodies against SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all